Amneal expands injectables portfolio with 6 new therapiesWith these new launches, Amneal now provides 13 injectables that are on the ASHP shortage list. Watch DSN: Community Unites for Discount Drug Mart’s Drug Take Back DayThe regional chain collects expired prescriptions to keep them out of vulnerable hands and out of the waterways. Alembic launches generic Retin-A Cream Tretinoin cream 0.1% is indicated for topical application in the treatment of acne vulgaris. MedAdvisor Solutions debuts Omnichannel Engagement for Pharmacy Omnichannel Engagement for Pharmacy allows pharmacies to deliver smart patient messaging while giving time back to pharmacists. Amphastar announces additional $50M increase to its Share Buyback Program The primary goal of the program is to offset dilution created by the company's equity compensation programs. Hospitals deploy technology, tap pharmacy technicians to improve safety, survey finds Pharmacists in hospitals and health systems continue to enhance their focus on management of drug therapy and clinical activities. Lupin receives tentative FDA OK for generic Prevymis, launches generic Vibramycin Letermovir tablets had a market value of roughly $314 million, while doxycycline for injection had a market value of approximately $48 million. FDA approves Amgen's Soliris biosimilar Amgen’s Bkemv is the first interchangeable biosimilar to Soliris to treat certain rare diseases. AAM submits comments to HHS, FTC on impact of GPOs, wholesalers on access to generic medicines AAM's letter requests that the FTC issue a section 6(b) Order to investigate the contracting practices of buying groups that contribute to the root causes of drug shortages. Meet the 2024 REX Technology and Automation Award Winners June’s awards feature companies in the technology and automation industry. First Previous 69 70 71 72 73 Next Last
